New catalytic approach creates key part of incontinence drug in much less time

Researchers have developed a novel catalyst that guarantees to revolutionize drug synthesis. It overcomes a standard downside related to the manufacturing of medication from ketones. Utilizing their catalyst, the researchers synthesized a key part of the generally used incontinence drug oxybutynin. Their outcomes underscore the potential of the catalyst to enhance drug discovery and improvement.